JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 2 |
AT&T
T
|
+$543M |
| 3 |
Boston Scientific
BSX
|
+$534M |
| 4 |
McDonald's
MCD
|
+$493M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$445M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
Broadcom
AVGO
|
+$618M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$511M |
| 5 |
JAH
JARDEN CORPORATION
JAH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.58% |
| 2 | Financials | 12.98% |
| 3 | Technology | 10.83% |
| 4 | Healthcare | 10.56% |
| 5 | Consumer Discretionary | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
Corvus Pharmaceuticals
CRVS
$914M
| $2.5M | ﹤0.01% |
+175,100
| New | +$2.37M |
2016 Q2
0 quarters
|
|
|
EOCC
2552
DELISTED
Enel Generacion Chile S.A.
EOCC
| $2.5M | ﹤0.01% |
89,996
+87,200
| +3,119% | +$2.36M |
2015 Q4
2 quarters
|
|
2553
Matthews International
MATW
$590M
| $2.5M | ﹤0.01% |
44,837
+17,402
| +63% | +$918K |
2013 Q2
12 quarters
|
|
2554
First Trust Utilities AlphaDEX Fund
FXU
$732M
| $2.49M | ﹤0.01% |
92,149
+35,007
| +61% | +$897K |
2015 Q4
2 quarters
|
|
2555
Alkermes
ALKS
$6.99B
| $2.49M | ﹤0.01% |
57,549
-192,100
| -77% | -$7.93M |
2013 Q2
12 quarters
|
|
|
IPXL
2556
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.48M | ﹤0.01% |
86,205
+14,008
| +19% | +$457K |
2013 Q2
12 quarters
|
|
2557
Designer Brands
DBI
$307M
| $2.48M | ﹤0.01% |
116,941
+115,306
| +7,052% | +$2.65M |
2015 Q1
5 quarters
|
|
2558
Sierra Bancorp
BSRR
$519M
| $2.47M | ﹤0.01% |
148,088
-434
| -0.3% | -$7.53K |
2013 Q2
12 quarters
|
|
2559
CALL
Hawaiian Electric Industries
HE
$1.55B
| $2.46M | ﹤0.01% |
+75,000
| New | +$2.47M |
2016 Q2
0 quarters
|
|
|
AVNS
2560
DELISTED
Avanos Medical
AVNS
| $2.46M | ﹤0.01% |
75,588
-2,508
| -3% | -$76.8K |
2014 Q4
6 quarters
|
|
|
BRKL
2561
DELISTED
Brookline Bancorp
BRKL
| $2.43M | ﹤0.01% |
220,379
+35,061
| +19% | +$392K |
2015 Q2
4 quarters
|
|
2562
Independent Bank Corp
IBCP
$803M
| $2.43M | ﹤0.01% |
167,425
+72,325
| +76% | +$1.07M |
2015 Q3
3 quarters
|
|
2563
Karyopharm Therapeutics
KPTI
$17.1M
| $2.43M | ﹤0.01% |
24,132
+5,452
| +29% | +$708K |
2013 Q4
10 quarters
|
|
2564
PTC Therapeutics
PTCT
$5.32B
| $2.43M | ﹤0.01% |
345,941
+152,402
| +79% | +$1.12M |
2014 Q3
7 quarters
|
|
2565
First Business Financial Services
FBIZ
$589M
| $2.43M | ﹤0.01% |
103,400
-1,600
| -2% | -$38.7K |
2014 Q2
8 quarters
|
|
|
WBK
2566
DELISTED
Westpac Banking Corporation
WBK
| $2.42M | ﹤0.01% |
109,633
+2,045
| +2% | +$45.8K |
2013 Q2
12 quarters
|
|
|
RPTP
2567
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $2.41M | ﹤0.01% |
449,409
+129,974
| +41% | +$666K |
2015 Q4
2 quarters
|
|
2568
CONMED
CNMD
$1.4B
| $2.4M | ﹤0.01% |
50,366
+2,613
| +5% | +$111K |
2013 Q2
12 quarters
|
|
2569
Advanced Micro Devices
AMD
$1.04T
| $2.4M | ﹤0.01% |
466,398
+15,831
| +4% | +$61.5K |
2013 Q2
12 quarters
|
|
|
GNCMA
2570
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $2.4M | ﹤0.01% |
151,641
-194
| -0.1% | -$3.17K |
2015 Q1
5 quarters
|
|
2571
H.B. Fuller
FUL
$2.74B
| $2.4M | ﹤0.01% |
54,465
+32,906
| +153% | +$1.48M |
2014 Q4
6 quarters
|
|
|
CLR
2572
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.39M | ﹤0.01% |
52,801
-40,206
| -43% | -$1.58M |
2013 Q2
12 quarters
|
|
2573
iShares MSCI Pacific ex Japan ETF
EPP
$2.19B
| $2.39M | ﹤0.01% |
60,857
-10,336
| -15% | -$405K |
2013 Q2
12 quarters
|
|
|
HEES
2574
DELISTED
H&E Equipment Services
HEES
| $2.38M | ﹤0.01% |
125,117
-8,012
| -6% | -$151K |
2015 Q4
2 quarters
|
|
|
RRTS
2575
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $2.38M | ﹤0.01% |
12,758
+12,621
| +9,212% | +$2.95M |
2015 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2016 Portfolio in Review
As of Q2 2016, JP Morgan Chase held 5,277 positions worth $401B, up 2.7% from $391B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2016 filing shows 543 new, 2,005 increased, 1,674 reduced and 446 closed positions. Its largest new stake was S&P Global: 3,576,026 shares worth $384M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2016 buy was S&P Global: 3,576,026 shares worth $384M.
- JP Morgan Chase added most to Alphabet (Google) Class A in Q2 2016, an estimated $561M increase.
- JP Morgan Chase's biggest Q2 2016 reduction was Apple, cutting an estimated $916M.
- JP Morgan Chase fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $1.03B.
- JP Morgan Chase's ten largest holdings make up 16% of its $401B portfolio in Q2 2016.
- JP Morgan Chase opened 543 new positions and closed 446 in Q2 2016.
- JP Morgan Chase's portfolio value rose 2.7% quarter-over-quarter to $401B.
Based on JP Morgan Chase's 13F filing for Q2 2016, filed 8 Aug 2016.